United States Pharmacopeia | Strategic Alliance Partners

Pharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.

Pharmacist-led services are not only important during COVID-19 immunization efforts in the United States, but are additionally critical in vaccination endeavors globally.

Farah Towfic, PharmD, MBA, director, CEO operations at US Pharmacopeia (USP), discusses USP’s release of an updated version of its COVID-19 Vaccine Handling Toolkit in response to feedback from independent pharmacies to mass vaccination clinics.

Pharmacy Times® interviewed Farah Towfic, PharmD, MBA, the director and CEO of operations at US Pharmacopeia, on the FDA’s approval of the Pfizer and BioNTech COVID-19 vaccine’s updated cold storage requirements.

Pharmacy Times® interviewed Nurisha Wade, MBA, and Farah Towfic, PharmD, MBA, of US Pharmacopeia, on how the release of the COVID-19 Vaccine Handling Toolkit may help pharmacists quickly and safely vaccinate.

The US Pharmacopeia (USP) is providing free technical assistance to developers of antiviral drugs and vaccines that will support the public health response to the coronavirus disease 2019 (COVID-19) pandemic.

To truly become the best versions of ourselves, it is important to constantly seek challenges that expand our personal limits and horizons.